Stem cells on the brain: Modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells

Journal of Neurogenetics

Volumn 28, Issue 1-2, 2014, Pages 5-29

  Srikanth, Priya ^a,b   Young Pearse, Tracy L ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Induced pluripotent stem cells; Modeling; Neurodegenerative; Neurodevelopmental

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; FIBROBLAST GROWTH FACTOR 2; LEUCINE RICH REPEAT KINASE 2;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ATAXIA TELANGIECTASIA; BRAIN CELL; CELL FATE; CHOLINERGIC NERVE CELL; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DYSAUTONOMIA; FRAGILE X SYNDROME; FRIEDREICH ATAXIA; FRONTOTEMPORAL DEMENTIA; GAUCHER DISEASE; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUNTINGTON CHOREA; IN VITRO STUDY; IN VIVO STUDY; MICROCEPHALY; MOTONEURON; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEURONAL CEROID LIPOFUSCINOSIS; NIEMANN PICK DISEASE; OLIGODENDROGLIA; PARKINSON DISEASE; PHENOTYPE; PHLEUM PRATENSE; PLURIPOTENT STEM CELL; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA CELL; RETINA GYRATE ATROPHY; RETINA MACULA VITELLIFORM DEGENERATION; RETINITIS PIGMENTOSA; RETT SYNDROME; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC NERVE CELL; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SYSTEMATIC REVIEW; X CHROMOSOME INACTIVATION; ADULT STEM CELL; ANIMAL; BRAIN; CYTOLOGY; DEVELOPMENTAL DISABILITIES; NEURODEGENERATIVE DISEASES; PHYSIOLOGY; PROCEDURES; STEM CELL TRANSPLANTATION;

ADULT STEM CELLS; ANIMALS; BRAIN; DEVELOPMENTAL DISABILITIES; HUMANS; NEURODEGENERATIVE DISEASES; PLURIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 84901414493     PISSN: 01677063     EISSN: 15635260     Source Type: Journal    
DOI: 10.3109/01677063.2014.881358     Document Type: Review

References (245)

1. Achyuta, A. K. H., Conway, A. J., Crouse, R. B., Bannister, E. C., Lee, R. N., Katnik, C. P., et al. (2013). A modular approach to create a neurovascular unit-on-a-chip. Lab Chip, 13, 542-553. doi:10. 1039/c2lc41033h
2. Almeida, S., Gascon, E., Tran, H., Chou, H. J., Gendron, T. F., DeGroot, S., et al. (2013). Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol, 126, 385-399. doi:10. 1007/s00401-013-1149-y
3. Almeida, S., Zhang, Z., Coppola, G., Mao, W., Futai, K., Karydas, A., et al. (2012). Induced pluripotent stem cell models of progranulin-defi cient frontotemporal dementia uncover specifi c reversible neuronal defects. Cell Rep, 2, 789-798. doi:10. 1016/j. celrep. 2012. 09. 007
4. Amenduni, M., De Filippis, R., Cheung, A. Y. L., Disciglio, V., Epistolato, M. C., Ariani, F., et al. (2011). iPS cells to model CDKL5-related disorders. Eur J Hum Genet, 19, 1246-1255. doi:10. 1038/ejhg. 2011. 131
5. Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet, 23, 185-188. doi:10. 1038/13810 (Pubitemid 29455390)
6. An, M. C., Zhang, N., Scott, G., Montoro, D., Wittkop, T., Mooney, S., et al. (2012). Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells. Cell Stem Cell, 11, 253-263. doi:10. 1016/j. stem. 2012. 04. 026
7. Ananiev, G., Williams, E. C., Li, H., & Chang, Q. (2011). Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model. PLoS ONE, 6, e25255. doi:10. 1371/journal. pone. 0025255. s007
8. Aubry, L., Bugi, A., Lefort, N., Rousseau, F., Peschanski, M., & Perrier, A. L. (2008). Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc Natl Acad Sci U S A, 105, 16707-16712. doi:10. 1073/pnas. 0808488105
9. Berdichevsky, Y., Staley, K. J., & Yarmush, M. L. (2010). Building and manipulating neural pathways with microfl uidics. Lab Chip, 10, 999-1004. doi:10. 1039/b922365g
10. Bertram, L., Lill, C. M., & Tanzi, R. E. (2010). The genetics of Alzheimer disease: Back to the future. Neuron, 68, 270-281. doi:10. 1016/j. neuron. 2010. 10. 013
11. Bilican, B., Serio, A., Barmada, S. J., Nishimura, A. L., Sullivan, G. J., Carrasco, M., et al. (2012). Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specifi c vulnerability. Proc Natl Acad Sci U S A, 109, 5803-5808. doi:10. 1073/pnas. 1202922109
12. Bissonnette, C. J., Lyass, L., Bhattacharyya, B. J., Belmadani, A., Miller, R. J., & Kessler, J. A. (2011). The controlled generation of functional basal forebrain cholinergic neurons from human embryonic stem cells. Stem Cells, 29, 802-811. doi:10. 1002/stem. 626
13. Bock, C., Kiskinis, E., Verstappen, G., Gu, H., Boulting, G., Smith, Z. D., et al. (2011). Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell, 144, 439-452. doi:10. 1016/j. cell. 2010. 12. 032
14. Boulting, G. L., Kiskinis, E., Croft, G. F., Amoroso, M. W., Oakley, D. H., Wainger, B. J., et al. (2011). A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol, 29, 279-286. doi:10. 1038/nbt. 1783
15. Brandon, N. J., & Sawa, A. (2011). Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci, 12, 707-722. doi:10. 1038/nrn3120
16. Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., et al. (2011). Modelling schizophrenia using human induced pluripotent stem cells. Nature, 473, 221-225. doi:10. 1038/nature09915
17. Buchholz, D. E., Hikita, S. T., Rowland, T. J., Friedrich, A. M., Hinman, C. R., Johnson, L. V., & Clegg, D. O. (2009). Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells, 27, 2427-2434. doi:10. 1002/stem. 189
18. Burkhardt, M. F., Martinez, F. J., Wright, S., Ramos, C., Volfson, D., Mason, M., et al. (2010). A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol Cell Neurosci, 56, 355-364. doi:10. 1016/j. mcn. 2013. 07. 007
19. Byers, B., Cord, B., Nguyen, H. N., Sch ü le, B., Fenno, L., Lee, P. C., et al. (2011). SNCA Triplication Parkinson's Patient's iPSC-derived DA neurons accumulate synuclein and are susceptible to oxidative stress. PLoS ONE, 6, e26159. doi:10. 1371/journal. pone. 0026159. s011
20. Camnasio, S., Carri, A. D., Lombardo, A., Grad, I., Mariotti, C., Castucci, A., et al. (2012). The fi rst reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol Dis, 46, 41-51. doi:10. 1016/j. nbd. 2011. 12. 042
21. Carlson, D. F., Fahrenkrug, S. C., & Hackett, P. B. (2012). Targeting DNA with fi ngers and TALENs. Mol Ther Nucleic Acids, 1, e3. doi:10. 1038/mtna. 2011. 5
22. Chahrour, M., & Zoghbi, H. Y. (2007). The story of Rett syndrome: From clinic to neurobiology. Neuron, 56, 422-437. doi:10. 1016/j. neuron. 2007. 10. 001 (Pubitemid 350026269)
23. Chamberlain, S. J., Chen, P.-F., Ng, K. Y., Bourgois-Rocha, F., Lemtiri-Chlieh, F., Levine, E. S., & Lalande, M. (2010). Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc Natl Acad Sci U S A, 107, 17668-17673. doi:10. 1073/pnas. 1004487107
24. Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009). Highly effi cient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol, 27, 275-280. doi:10. 1038/nbt. 1529
25. Chambers, S. M., Mica, Y., Lee, G., Studer, L., & Tomishima, M. J. (2013). Dual-SMAD inhibition/WNT activation-based methods to induce neural crest and derivatives from human pluripotent stem cells. Methods Mol Biol, doi:10. 1007/7651-2013-59
26. Chambers, S. M., Qi, Y., Mica, Y., Lee, G., Zhang, X.-J., Niu, L., et al. (2012). Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat Biotechnol, 30, 715-720. doi:10. 1038/nbt. 2249
27. Chetty, S., Pagliuca, F. W., Honore, C., Kweudjeu, A., Rezania, A., & Melton, D. A. (2013). A simple tool to improve pluripotent stem cell differentiation. Nat Methods, 10, 553-556. doi:10. 1038/nmeth. 2442
28. Cheung, A. Y. L., Horvath, L. M., Grafodatskaya, D., Pasceri, P., Weksberg, R., Hotta, A., et al. (2011). Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum Mol Genet, 20, 2103-2115. doi:10. 1093/hmg/ddr093
29. Chiang, C.-H., Su, Y., Wen, Z., Yoritomo, N., Ross, C. A., Margolis, R. L., et al. (2011). Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry, 16, 358-360. doi:10. 1038/mp. 2011. 13
30. Chi ò, A., Logroscino, G., Traynor, B. J., Collins, J., Simeone, J. C., Goldstein, L. A., & White, L. A. (2013). Global epidemiology of amyotrophic lateral sclerosis: A systematic review of the published literature. Neuroepidemiology, 41, 118-130. doi:10. 1159/000351153
31. Cho, M.-S., Hwang, D.-Y., & Kim, D. W. (2008a). Effi cient derivation of functional dopaminergic neurons from human embryonic stem cells on a large scale. Nat Protocols, 3, 1888-1894. doi:10. 1038/nprot. 2008. 188
32. Cho, M.-S., Lee, Y.-E., Kim, J. Y., Chung, S., Cho, Y. H., Kim, D.-S., et al. (2008b). Highly effi cient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A, 105, 3392-3397. doi:10. 1073/pnas. 0712359105 (Pubitemid 351723563)
33. Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., et al. (2013). Multiplex genome engineering using CRISPR/Cas systems. Science, 339, 819-823. doi:10. 1126/science. 1231143
34. Cooper, O., Hargus, G., Deleidi, M., Blak, A., Osborn, T., Marlow, E., et al. (2010). Molecular and cellular neuroscience. Mol Cell Neurosci, 45, 258-266. doi:10. 1016/j. mcn. 2010. 06. 017
35. Cooper, O., Seo, H., Andrabi, S., Guardia-Laguarta, C., Graziotto, J., Sundberg, M., et al. (2012). Pharmacological rescue of mitochondrial defi cits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med, 4, 141ra90. doi:10. 1126/scitranslmed. 3003985
36. Corti, S., Nizzardo, M., Simone, C., Falcone, M., Nardini, M., Ronchi, D., et al. (2012). Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy. Sci Transl Med, 4, 165ra162. doi:10. 1126/scitranslmed. 3004108
37. Czepiel, M., Balasubramaniyan, V., Schaafsma, W., Stancic, M., Mikkers, H., Huisman, C., et al. (2011). Differentiation of induced pluripotent stem cells into functional oligodendrocytes. Glia, 59, 882-892. doi:10. 1002/glia. 21159
38. de Lau, L. M. L., & Breteler, M. M. B. (2006). Epidemiology of Parkinson's disease. Lancet Neurol, 5, 525-535. doi:10. 1016/S1474-4422(06) 70471-9
39. Delli Carri, A., Onorati, M., Castiglioni, V., Faedo, A., Camnasio, S., Toselli, M., et al. (2013a). Human pluripotent stem cell differentiation into authentic striatal projection neurons. Stem Cell Rev Rep, 9, 461-474. doi:10. 1007/s12015-013-9441-8
40. Delli Carri, A., Onorati, M., Lelos, M. J., Castiglioni, V., Faedo, A., Menon, R., et al. (2013b). Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32-mediumsized spiny neurons. Development, 140, 301-312. doi:10. 1242/dev. 084608
41. Denton, K. R., Lei, L., Grenier, J., Rodionov, V., Blackstone, C., & Li, X.-J. (2014). Loss of spastin function results in disease-specifi c axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia. Stem Cells, 32, 414-423. doi:10. 1002/stem. 1569
42. Devine, M. J., Ryten, M., Vodicka, P., Thomson, A. J., Burdon, T., Houlden, H., et al. (2011). Parkinson ' s disease induced pluripotent stem cells with triplication of the. Nat Commun, 2, 440. doi:10. 1038/ncomms1453
43. Dhara, S. K., & Stice, S. L. (2008). Neural differentiation of human embryonic stem cells. J Cell Biochem, 105, 633-640. doi:10. 1002/jcb. 21891
44. Di Giorgio, F. P., Boulting, G. L., Bobrowicz, S., & Eggan, K. C. (2008). Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Stem Cell, 3, 637-648. doi:10. 1016/j. stem. 2008. 09. 017
45. Di Giorgio, F. P., Carrasco, M. A., Siao, M. C., Maniatis, T., & Eggan, K. (2007). Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci, 10, 608-614. doi:10. 1038/nn1885 (Pubitemid 46652442)
46. Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., et al. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 321, 1218-1221. doi:10. 1126/science. 1158799
47. Dincer, Z., Piao, J., Niu, L., Ganat, Y., Kriks, S., Zimmer, B., et al. (2013). Specifi cation of functional cranial placode derivatives from human pluripotent stem cells. Cell Rep, 5, 1387-1402. doi:10. 1016/j. celrep. 2013. 10. 048
48. Ding, Q., Lee, Y.-K., Schaefer, E. A. K., Peters, D. T., Veres, A., Kim, K., et al. (2013a). A TALEN genome-editing system for generating human stem cell-based disease models. Stem Cell, 12, 238-251. doi:10. 1016/j. stem. 2012. 11. 011
49. Ding, Q., Regan, S. N., Xia, Y., Oostrom, L. A., Cowan, C. A., & Musunuru, K. (2013b). Enhanced effi ciency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Stem Cell, 12, 393-394. doi:10. 1016/j. stem. 2013. 03. 006
50. Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., et al. (2013). RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron, 80, 415-428. doi:10. 1016/j. neuron. 2013. 10. 015
51. Doyon, Y., Vo, T. D., Mendel, M. C., Greenberg, S. G., Wang, J., Xia, D. F., et al. (2010). Enhancing zinc-fi nger-nuclease activity with improved obligate heterodimeric architectures. Nat Methods, 8, 74-79. doi:10. 1038/nmeth. 1539
52. Eigentler, A., Boesch, S., Schneider, R., Dechant, G., & Nat, R. (2013). Induced pluripotent stem cells from Friedreich ataxia patients fail to upregulate frataxin during in vitro differentiation to peripheral sensory neurons. Stem Cells Dev, 22, 3271-3282. doi:10. 1089/scd. 2013. 0126
53. Eiraku, M., Watanabe, K., Matsuo-Takasaki, M., Kawada, M., Yonemura, S., Matsumura, M., et al. (2008). Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Stem Cell, 3, 519-532. doi:10. 1016/j. stem. 2008. 09. 002
54. Elkabetz, Y., Panagiotakos, G., Shamy, Al, G., Socci, N. D., Tabar, V., & Studer, L. (2008). Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev, 22, 152-165. doi:10. 1101/gad. 1616208
55. Emdad, L., D'Souza, S. L., Kothari, H. P., Qadeer, Z. A., & Germano, I. M. (2012). Effi cient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes. Stem Cells Dev, 21, 404-410. doi:10. 1089/scd. 2010. 0560
56. Erceg, S., La í nez, S., Ronaghi, M., Stojkovic, P., P é rez-Arag ó, M. A., Moreno-Manzano, V., et al. (2008). Differentiation of human embryonic stem cells to regional specifi c neural precursors in chemically defi ned medium conditions. PLoS ONE, 3, e2122. doi:10. 1371/journal. pone. 0002122. s004
57. Erceg, S., Lukovic, D., Moreno-Manzano, V., Stojkovic, M., & Bhattacharya, S. S. (2007). Derivation of cerebellar neurons from human pluripotent stem cells. Hoboken, NJ: John Wiley & Sons. doi:10. 1002/9780470151808. sc01h05s20
58. Erceg, S., Ronaghi, M., Zipancic, I., La í nez, S., Rosell ó, M. G., Xiong, C., et al. (2010). Effi cient differentiation of human embryonic stem cells into functional cerebellarlike cells. Stem Cells Dev, 19, 1745-1756. doi:10. 1089/scd. 2009. 0498
59. Erraji-Benchekroun, L., Underwood, M. D., Arango, V., Galfalvy, H., Pavlidis, P., Smyrniotopoulos, P., et al. (2005). Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry, 57, 549-558. doi:10. 1016/j. biopsych. 2004. 10. 034 (Pubitemid 40311991)
60. Espuny-Camacho, I., Michelsen, K. A., Gall, D., Linaro, D., Hasche, A., Bonnefont, J., et al. (2013). Pyramidal neurons derived from human pluripotent stem cells integrate effi ciently into mouse brain circuits in vivo. Neuron, 77, 440-456. doi:10. 1016/j. neuron. 2012. 12. 011
61. Farra, N., Zhang, W.-B., Pasceri, P., Eubanks, J. H., Salter, M. W., & Ellis, J. (2012). Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations. Mol Psychiatry, 17, 1261-1271. doi:10. 1038/mp. 2011. 180
62. Fong, H., Wang, C., Knoferle, J., Walker, D., Balestra, M. E., Tong, L. M., et al. (2013). Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells. Stem Cell Rep, 1, 226-234. doi:10. 1016/j. stemcr. 2013. 08. 001
63. Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013). High-frequency off-target mutagenesis induced by CrIsPr-Cas nucleases in human cells. Nat Biotechnol, 31, 822-826. doi:10. 1038/nbt. 2623
64. Gaj, T., Gersbach, C. A., & Barbas, C. F., III. (2013). ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol, 31, 397-405. doi:10. 1016/j. tibtech. 2013. 04. 004
65. Gaspard, N., Bouschet, T., Hourez, R., Dimidschstein, J., Naeije, G., van den Ameele, J., et al. (2008). An intrinsic mechanism of corticogenesis from embryonic stem cells. Nature, 455, 351-357. doi:10. 1038/nature07287
66. Goulburn, A. L., Alden, D., Davis, R. P., Micallef, S. J., Ng, E. S., Yu, Q. C., et al. (2011a). A targeted NKX2. 1 human embryonic stem cell reporter line enables identifi cation of human basal forebrain derivatives. Stem Cells, 29, 462-473. doi:10. 1002/stem. 587
67. Goulburn, A. L., Stanley, E. G., Elefanty, A. G., & Anderson, S. A. (2011b). Generating GABAergic cerebral cortical interneurons from mouse and human embryonic stem cells. Stem Cell Res. 8, 416-426. doi:10. 1016/j. scr. 2011. 12. 002
68. Griep, L. M., Wolbers, F., Wagenaar, B., Braak, P. M., Weksler, B. B., Romero, I. A., et al. (2012). BBB ON CHIP: Microfl uidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed Microdevices, 15, 145-150. doi:10. 1007/s10544-012-9699-7
69. Guo, J., Gaj, T., & Barbas, C. F., III. (2010). Directed evolution of an enhanced and highly effi cient FokI cleavage domain for zinc fi nger nucleases. J Mol Biol, 400, 96-107. doi:10. 1016/j. jmb. 2010. 04. 060
70. Gupta, K., Patani, R., Baxter, P., Serio, A., Story, D., Tsujita, T., et al. (2011). Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanisms. Cell Death Differ, 19, 779-787. doi:10. 1038/cdd. 2011. 154
71. HD iPSC Consortium. (2012). Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell, 11, 264-278. doi:10. 1016/j. stem. 2012. 04. 027
72. Hester, M. E., Murtha, M. J., Song, S., Rao, M., Miranda, C. J., Meyer, K., et al. (2011). Rapid and effi cient generation of functional motor neurons from human pluripotent stem cells using gene delivered transcription factor codes. Mol Ther, 19, 1905-1912. doi:10. 1038/mt. 2011. 135
73. Hick, A., Wattenhofer-Donze, M., Chintawar, S., Tropel, P., Simard, J. P., Vaucamps, N., et al. (2013). Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia. Dis Model Mech, 6, 608-621. doi:10. 1242/dmm. 010900
74. Higurashi, N., Uchida, T., Lossin, C., Misumi, Y., Okada, Y., Akamatsu, W., et al. (2013). A human Dravet syndrome model from patient induced pluripotent stem cells. Mol Brain, 6, 19. doi:10. 1186/1756-6606-6-19
75. Hirami, Y., Osakada, F., Takahashi, K., Okita, K., Yamanaka, S., Ikeda, H., et al. (2009). Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett, 458, 126-131. doi:10. 1016/j. neulet. 2009. 04. 035
76. Hockemeyer, D., Wang, H., Kiani, S., Lai, C. S., Gao, Q., Cassady, J. P., et al. (2011). Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol, 29, 731-734. doi:10. 1038/nbt. 1927
77. Hotta, A., Cheung, A. Y. L., Farra, N., Vijayaragavan, K., Séguin, C. A., Draper, J. S., et al. (2009). Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods, 6, 370-376. doi:10. 1038/nmeth. 1325
78. Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., et al. (2013). DNA targeting specifi city of RNA-guided Cas9 nucleases. Nat Biotechnol, 31, 827-832. doi:10. 1038/nbt. 2647
79. Hu, B.-Y., & Zhang, S.-C. (2009). Differentiation of spinal motor neurons from pluripotent human stem cells. Nat Protocols, 4, 1295-1304. doi:10. 1038/nprot. 2009. 127
80. Hu, B. Y., Weick, J. P., Yu, J., Ma, L. X., Zhang, X. Q., Thomson, J. A., & Zhang, S. C. (2010). Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A, 107, 4335-4340. doi:10. 1073/pnas. 0910012107
81. Huang, P., Xiao, A., Zhou, M., Zhu, Z., Lin, S., & Zhang, B. (2011). Heritable gene targeting in zebrafi sh using customized TALENs. Nature Publishing Group, 29, 699-700. doi:10. 1038/nbt. 1939
82. Huang, Y., Williams, J. C., & Johnson, S. M. (2012). Brain slice on a chip: Opportunities and challenges of applying microfl uidic technology to intact tissues. Lab Chip, 12, 2103-2117. doi:10. 1039/c2lc21142d
83. Huisman, M. H. B., de Jong, S. W., van Doormaal, P. T. C., Weinreich, S. S., Schelhaas, H. J., van der Kooi, A. J., et al. (2011). Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol, Neurosurg Psychiatry, 82, 1165-1170. doi:10. 1136/jnnp. 2011. 244939
84. Iacovitti, L., Donaldson, A. E., Marshall, C. E., Suon, S., & Yang, M. (2007). A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defi ned human additives: Studies in vitro and in vivo. Brain Res, 1127, 19-25. doi:10. 1016/j. brainres. 2006. 10. 022 (Pubitemid 44856720)
85. Imaizumi, Y., Okada, Y., Akamatsu, W., Koike, M., Kuzumaki, N., Hayakawa, H., et al. (2012). Mitochondrial dysfunction associated with increased oxidative stress and synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol Brain, 5, 35. doi:10. 1186/1756-6606-5-35
86. Insel, T. R. (2010). Rethinking schizophrenia. Nature, 468, 187-193. doi:10. 1038/nature09552
87. Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., et al. (2012). Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature, 482, 216-220. doi:10. 1038/nature10821
88. Jaaro-Peled, H. (2009). Gene models of schizophrenia: DISC1 mouse models. Prog Brain Res, 179, 75-86. doi:10. 1016/S0079-6123(09)17909-8
89. Jacquemont, S., Hagerman, R. J., Hagerman, P. J., & Leehey, M. A. (2007). Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: Two faces of FMR1. Lancet Neurol, 6, 45-55. doi:10. 1016/S1474-4422(06)70676-7 (Pubitemid 44880272)
90. Jeon, I., Lee, N., Li, J.-Y., Park, I.-H., Park, K. S., Moon, J., et al. (2012). Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells. Stem Cells, 30, 2054-2062. doi:10. 1002/stem. 1135
91. Jiang, X., Gwye, Y., McKeown, S. J., Bronner-Fraser, M., Lutzko, C., & Lawlor, E. R. (2009). Isolation and characterization of neural crest stem cells derived from in vitro-differentiated human embryonic stem cells. Stem Cells Dev, 18, 1059-1070. doi:10. 1089/scd. 2008. 0362
92. Jiao, J., Yang, Y., Shi, Y., Chen, J., Gao, R., Fan, Y., et al. (2013). Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons. Hum Mol Genet, 22, 4241-4252. doi:10. 1093/hmg/ddt275
93. Jin, Z.-B., Okamoto, S., Osakada, F., Homma, K., Assawachananont, J., Hirami, Y., et al. (2011). Modeling retinal degeneration using patient-specifi c induced pluripotent stem cells. PLoS ONE, 6, e17084. doi:10. 1371/journal. pone. 0017084. s013
94. Jin, Z. B., Okamoto, S., Xiang, P., & Takahashi, M. (2012). Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling. Stem Cells Transl Med, 1, 503-509. doi:10. 5966/sctm. 2012-0005
95. Juopperi, T. A., Kim, W. R., Chiang, C.-H., Yu, H., Margolis, R. L., Ross, C. A., et al. (2012). Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington ' s disease patient cells. Mol Brain, 5, 17. doi:10. 1186/1756-6606-5-17
96. Kang, S.-M., Cho, M.-S., Seo, H., Yoon, C. J., Oh, S. K., Choi, Y. M., & Kim, D. W. (2007). Effi cient induction of oligodendrocytes from human embryonic stem cells. Stem Cells, 25, 419-424. doi:10. 1634/stemcells. 2005-0482 (Pubitemid 46232797)
97. Karumbayaram, S., Novitch, B. G., Patterson, M., Umbach, J. A., Richter, L., Lindgren, A., et al. (2009). Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells, 27, 806-811. doi:10. 1002/stem. 31
98. Khademhosseini, A., Langer, R., Borenstein, J., & Vacanti, J. P. (2006). Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A, 103, 2480-2487. doi:10. 1073/pnas. 0507681102
99. Kim, E., Kim, S., Kim, D. H., Choi, B. S., Choi, I. Y., & Kim, J. S. (2012). Precision genome engineering with programmable DNA-nicking enzymes. Genome Res, 22, 1327-1333. doi:10. 1101/gr. 138792. 112
100. Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature, 467, 285-290. doi:10. 1038/nature09342
101. Kim, K.-Y., Hysolli, E., & Park, I.-H. (2011). Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proc Natl Acad Sci U S A, 108, 14169-14174. doi:10. 1073/pnas. 1018979108
102. Kim, S., & Webster, M. J. (2008). Correlation analysis between genome-wide expression profi les and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol Psychiatry, 15, 326-336. doi:10. 1038/mp. 2008. 99
103. Kirkeby, A., Grealish, S., Wolf, D. A., Nelander, J., Wood, J., Lundblad, M., et al. (2012). Generation of regionally specifi ed neural progenitors and functional neurons from human embryonic stem cells under defi ned conditions. Cell Rep, 1, 703-714. doi:10. 1016/j. celrep. 2012. 04. 009
104. Ko, J.-Y., Park, C.-H., Koh, H.-C., Cho, Y.-H., Kyhm, J.-H., Kim, Y.-S., et al. (2007). Human embryonic stem cell-derived neural precursors as a continuous, stable, and on-demand source for human dopamine neurons. J Neurochem, 103, 1417-1429. doi:10. 1111/j. 1471-4159. 2007. 04898. x (Pubitemid 47631832)
105. Koehler, K. R., Tropel, P., Theile, J. W., Kondo, T., Cummins, T. R., Viville, S., & Hashino, E. (2011). Extended passaging increases the effi ciency of neural differentiation from induced pluripotent stem cells. BMC Neurosci, 12, 82. doi:10. 1073/pnas. 0408239102
106. Kokkinaki, M., Sahibzada, N., & Golestaneh, N. (2011). Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE. Stem Cells, 29, 825-835. doi:10. 1002/stem. 635
107. Kondo, T., Johnson, S. A., Yoder, M. C., Romand, R., & Hashino, E.,. (2005). Sonic hedgehog and retinoic acid synergistically promote sensory fate specifi cation from bone marrowderived pluripotent stem cells. Proc Natl Acad Sci U S A, 102, 4789-4794. doi:10. 1073/pnas. 0408239102 (Pubitemid 40471532)
108. Kondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., et al. (2013). Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular A and differential drug responsiveness. Stem Cell, 12, 487-496. doi:10. 1016/j. stem. 2013. 01. 009
109. Koyanagi-Aoi, M., Ohnuki, M., Takahashi, K., Okita, K., Noma, H., Sawamura, Y., et al. (2013). Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proc Natl Acad Sci U S A,, 110, 20569-20574 doi:10. 1073/pnas. 1319061110
110. Krencik, R., & Zhang, S.-C. (2006). Stem cell neural differentiation: A model for chemical biology. Curr Opin Chem Biol, 10, 592-597. doi:10. 1016/j. cbpa. 2006. 10. 002 (Pubitemid 44830123)
111. Krencik, R., Weick, J. P., Liu, Y., Zhang, Z.-J., & Zhang, S.-C. (2011). specifi cation of transplantable astroglial subtypes from human pluripotent stem cells. Nat Biotechnol, 29, 528-534. doi:10. 1038/nbt. 1877
112. Kriks, S., Shim, J.-W., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., et al. (2011). Dopamine neurons derived from human ES cells effi ciently engraft in animal models of Parkinson's disease. Nature, 480, 547-551. doi:10. 1038/nature10648
113. Ku, S., Soragni, E., Campau, E., Thomas, E. A., Altun, G., Laurent, L. C., et al. (2010). Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA TTC triplet repeat instability. Stem Cell, 7, 631-637. doi:10. 1016/j. stem. 2010. 09. 014
114. Kumamaru, H., Ohkawa, Y., Saiwai, H., Yamada, H., Kubota, K., Kobayakawa, K., et al. (2012). Direct isolation and RNA-seq reveal environment-dependent properties of engrafted neural stem/progenitor cells. Nat Commun, 3, 1140. doi:10. 1038/ncomms2132
115. Kunze, A., Giugliano, M., Valero, A., & Renaud, P. (2011). Micropatterning neural cell cultures in 3D with a multi-layered scaffold. Biomaterials, 32, 2088-2098. doi:10. 1016/j. biomaterials. 2010. 11. 047
116. Lamba, D. A., Karl, M. O., Ware, C. B., & Reh, T. A. (2006). Effi cient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci U S A, 103, 12769-12774. doi:10. 1073/pnas. 0601990103 (Pubitemid 44298636)
117. Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., et al. (2013). Cerebral organoids model human brain development and microcephaly. Nature, 501, 373-379. doi:10. 1038/nature12517
118. Larimore, J., Ryder, P. V., Kim, K.-Y., Ambrose, L. A., Chapleau, C., Calfa, G., et al. (2013). MeCP2 regulates the synaptic expression of a dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cellderived neurons. PLoS ONE, 8, e65069. doi:10. 1371/journal. pone. 0065069. t001
119. Lee, D. S., Yu, K., Rho, J.-Y., Lee, E., Han, J.-S., Koo, D.-B., et al. (2006). Cyclopamine treatment of human embryonic stem cells followed by culture in human astrocyte medium promotes differentiation into nestin-and GFAP-expressing astrocytic lineage. Life Sci, 80, 154-159. doi:10. 1016/j. lfs. 2006. 08. 039 (Pubitemid 44853981)
120. Lee, G., Chambers, S. M., Tomishima, M. J., & Studer, L. (2010). Derivation of neural crest cells from humanpluripotent stem cells. Nat Protocols, 5, 688-701. doi:10. 1038/nprot. 2010. 35
121. Lee, G., Kim, H., Elkabetz, Y., Shamy, Al, G., Panagiotakos, G., Barberi, T., et al. (2007a). Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol, 25, 1468-1475. doi:10. 1038/nbt1365 (Pubitemid 350233140)
122. Lee, G., Papapetrou, E. P., Kim, H., Chambers, S. M., Tomishima, M. J., Fasano, C. A., et al. (2009). Modelling pathogenesis and treatment of familial dysautonomia using patient-specifi c iPSCs. Nature, 461, 402-406. doi:10. 1038/nature08320
123. Lee, H., Shamy, G. A., Elkabetz, Y., Schofi eld, C. M., Harrsion, N. L., Panagiotakos, G., et al. (2007b). Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells, 25, 1931-1939. doi:10. 1634/stemcells. 2007-0097 (Pubitemid 47258171)
124. Lee, K. S., Zhou, W., Scott-McKean, J. J., Emmerling, K. L., Cai, G.-Y., Krah, D. L., et al. (2012). Human sensory neurons derived from induced pluripotent stem cells support varicella-zoster virus infection. PLoS ONE, 7, e53010. doi:10. 1371/journal. pone. 0053010. g006
125. Lee, P., Martin, N. T., Nakamura, K., Azghadi, S., Amiri, M., Ben-David, U., et al. (2013). SMRT compounds abrogate cellular phenotypes of ataxia telangiectasia in neural derivatives of patient-specifi c hiPSCs. Nat Commun, 4, 1824. doi:10. 1038/ncomms2824
126. Lewis, D. A., & Levitt, P. (2002). Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci, 25, 409-432. doi:10. 1146/annurev. neuro. 25. 112701. 142754 (Pubitemid 34748023)
127. Li, W., Sun, W., Zhang, Y., Wei, W., Ambasudhan, R., Xia, P., et al. (2011). Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors. Proc Natl Acad Sci U S A, 108, 8299-8304. doi:10. 1073/pnas. 1014041108
128. Li, X.-J., Du, Z.-W., Zarnowska, E. D., Pankratz, M., Hansen, L. O., Pearce, R. A., & Zhang, S.-C. (2005). Specifi cation of motoneurons from human embryonic stem cells. Nat Biotechnol, 23, 215-221. doi:10. 1038/nbt1063 (Pubitemid 40255332)
129. Li, X.-J., Hu, B.-Y., Jones, S. A., Zhang, Y.-S., LaVaute, T., Du, Z.-W., & Zhang, S.-C. (2008). Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules. Stem Cells, 26, 886-893. doi:10. 1634/stemcells. 2007-0620
130. Li, X. J., Zhang, X., Johnson, M. A., Wang, Z. B., LaVaute, T., & Zhang, S. C. (2009). Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development, 136, 4055-4063. doi:10. 1242/dev. 036624
131. Lin, M., Hrabovsky, A., Pedrosa, E., Wang, T., Zheng, D., & Lachman, H. M. (2012). Allele-biased expression in differentiating human neurons: Implications for neuropsychiatric disorders. PLoS ONE, 7, e44017. doi:10. 1371/journal. pone. 0044017. s007
132. Liu, G.-H., Barkho, B. Z., Ruiz, S., Diep, D., Qu, J., Yang, S.-L., et al. (2011a). Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature, 472, 221-225. doi:10. 1038/nature09879
133. Liu, G.-H., Ding, Z., & Belmonte, J. C. I. (2012a). iPSC technology to study human aging and aging-related disorders. Curr Opin Cell Biol, 24, 765-774. doi:10. 1016/j. ceb. 2012. 08. 014
134. Liu, G.-H., Qu, J., Suzuki, K., Nivet, E., Li, M., Montserrat, N., et al. (2012b). Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. Nature, 491, 603-607. doi:10. 1038/nature11557
135. Liu, H., & Zhang, S.-C. (2011). Specifi cation of neuronal and glial subtypes from human pluripotent stem cells. Cell Mol Life Sci, 68, 3995-4008. doi:10. 1007/s00018-011-0770-y
136. Liu, J., Koscielska, K. A., Cao, Z., Hulsizer, S., Grace, N., Mitchell, G., et al. (2012c). Signaling defects in iPSCderived fragile X premutation neurons. Hum Mol Genet, 21, 3795-3805. doi:10. 1093/hmg/dds207
137. Liu, J., Verma, P. J., Evans-Galea, M. V., Delatycki, M. B., Michalska, A., Leung, J., et al. (2011b). Generation of induced pluripotent stem cell lines from Friedreich ataxia patients. Stem Cell Rev Rep, 7, 703-713. doi:10. 1007/s12015-010-9210-x
138. Liu, Q., Spusta, S. C., Mi, R., Lassiter, R. N. T., Stark, M. R., Hoke, A., et al. (2012d). Human neural crest stem cells derived from human ESCs and induced pluripotent stem cells: Induction, maintenance, and differentiation into functional Schwann cells. Stem Cells Transl Med, 1, 266-278. doi:10. 5966/sctm. 2011-0042
139. Liu, Y, Liu, H., Sauvey, C., Yao, L., Zarnowska, E. D., & Zhang, S.-C. (2013a). Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells. Nat Protocols, 8, 1670-1679. doi:10. 1038/nprot. 2013. 106
140. Liu, Yu, Lopez-Santiago, L. F., Yuan, Y., Jones, J. M., Zhang, H., O'Malley, H. A., et al. (2013b). Dravet syndrome patientderived neurons suggest a novel epilepsy mechanism. Ann Neurol, 74, 128-139. doi:10. 1002/ana. 23897
141. Lojewski, X., Staropoli, J. F., Biswas-Legrand, S., Simas, A. M., Haliw, L., Selig, M. K., et al. (2013). Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway. Hum Mol Genet. doi:10. 1093/hmg/ddt596
142. Ma, L., Hu, B., Liu, Y., Vermilyea, S. C., Liu, H., Gao, L., et al. (2012). Human embryonic stem cell-derived GABA neurons correct locomotion defi cits in quinolinic acidlesioned mice. Stem Cell, 10, 455-464. doi:10. 1016/j. stem. 2012. 01. 021
143. Mahley, R. W., & Rall, S. C. (2000). Apolipoprotein E: Far more than a lipid transport protein. Annu Rev Genomics Hum Genet, 1, 507-537. doi:10. 1146/annurev. genom. 1. 1. 507
144. Mali, P., Aach, J., Stranges, P. B., Esvelt, K. M., Moosburner, M., Kosuri, S., et al. (2013a). CAS9 transcriptional activators for target specifi city screening and paired nickases for cooperative genome engineering. Nat Biotechnol, 31, 833-838. doi:10. 1038/nbt. 2675
145. Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., et al. (2013b). RNA-guided human genome engineering via Cas9. Science, 339, 823-826. doi:10. 1126/science. 1232033
146. Marchetto, M. C. N., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., et al. (2010a). A model for neural developmentand treatment of Rett syndrome using human induced pluripotent stem cells. Cell, 143, 527-539. doi:10. 1016/j. cell. 2010. 10. 016
147. Marchetto, M. C. N., Muotri, A. R., Mu, Y., Smith, A. M., Cezar, G. G., & Gage, F. H. (2008). Non-cell-autonomous effect of human SOD1. Stem Cell, 3, 649-657. doi:10. 1016/j. stem. 2008. 10. 001
148. Marchetto, M. C. N., Winner, B., & Gage, F. H. (2010b). Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Human Mol Genet, 19 (R1), R71-R76. doi:10. 1093/hmg/ddq159
149. Marchetto, M. C. N., Yeo, G. W., Kainohana, O., Marsala, M., Gage, F. H., & Muotri, A. R. (2009). Transcriptional signature and memory retention of humaninduced pluripotent stem cells. PLoS ONE, 4, e7076. doi:10. 1371/journal. pone. 0007076. s012
150. Mariani, J., Simonini, M. V., Palejev, D., Tomasini, L., Coppola, G., Szekely, A. M., et al. (2012). Modeling human cortical development in vitro using induced pluripotent stem cells. Proc Natl Acad Sci U S A, 109, 12770-12775. doi:10. 1073/pnas. 1202944109
151. Maroof, A. M., Keros, S., Tyson, J. A., Ying, S.-W., Ganat, Y. M., Merkle, F. T., et al. (2013). Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Stem Cell, 12, 559-572. doi:10. 1016/j. stem. 2013. 04. 008
152. Mekhoubad, S., Bock, C., de Boer, A. S., Kiskinis, E., Meissner, A., & Eggan, K. (2012). Erosion of dosage compensation impacts human iPSC disease modeling. Stem Cell, 10, 595-609. doi:10. 1016/j. stem. 2012. 02. 014
153. Menendez, L., Kulik, M. J., Page, A. T., Park, S. S., Lauderdale, J. D., Cunningham, M. L., & Dalton, S. (2013). Directed differentiation of human pluripotent cells to neural crest stem cells. Nat Protocols, 8, 203-212. doi:10. 1038/nprot. 2012. 156
154. Menendez, L., Yatskievych, T. A., Antin, P. B., & Dalton, S. (2011). Wnt signaling and a Smad pathway blockade direct the differentiation of human pluripotent stem cells to multipotent neural crest cells. Proc Natl Acad Sci U S A, 108, 19240-19245. doi:10. 1073/pnas. 1113746108
155. Merkle, F. T., & Eggan, K. (2013). Modeling human disease with pluripotent stem cells: from genome association to function. Stem Cell, 12, 656-668. doi:10. 1016/j. stem. 2013. 05. 016
156. Meyer, J. S., Howden, S. E., Wallace, K. A., Verhoeven, A. D., Wright, L. S., Capowski, E. E., et al. (2011). Optic vesiclelike structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells, 29, 1206-1218. doi:10. 1002/stem. 674
157. Meyer, J. S., Shearer, R. L., Capowski, E. E., Wright, L. S., Wallace, K. A., McMillan, E. L., et al. (2009). Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A, 106, 16698-16703. doi:10. 1073/pnas. 0905245106
158. Mica, Y., Lee, G., Chambers, S. M., Tomishima, M. J., & Studer, L. (2013). Modeling Neural crest induction, melanocyte specifi cation, and disease-related pigmentation defects in hESCs and patient-specifi c iPSCs. Cell Rep, 3, 1140-1152. doi:10. 1016/j. celrep. 2013. 03. 025
159. Miller, J. C., Holmes, M. C., Wang, J., Guschin, D. Y., Lee, Y.-L., Rupniewski, I., et al. (2007). An improved zincfi nger nuclease architecture for highly specifi c genome editing. Nat Biotechnol, 25, 778-785. doi:10. 1038/nbt1319 (Pubitemid 47052191)
160. Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., et al. (2013). Human iPSC-based modeling of late-onset disease via progerin-induced aging. Stem Cell, 13, 691-705. doi:10. 1016/j. stem. 2013. 11. 006
161. Mitchell, K. J. (2011). The genetics of neurodevelopmental disease. Curr Opin Neurobiol, 21, 197-203. doi:10. 1016/j. conb. 2010. 08. 009
162. Mitne-Neto, M., Machado-Costa, M., Marchetto, M. C. N., Bengtson, M. H., Joazeiro, C. A., Tsuda, H., et al. (2011). Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum Mol Genet, 20, 3642-3652. doi:10. 1093/hmg/ddr284
163. Morgan, P. J., Liedmann, A., Hübner, R., Hovakimyan, M., Rolfs, A., & Frech, M. J. (2011). Human neural progenitor cells show functional neuronal differentiation and regional preference after engraftment onto hippocampal slice cultures. Stem Cells Dev. 21, 1501-1512. doi:10. 1089/scd. 2011. 0335
164. Morizane, A., Doi, D., & Takahashi, J. (2013). Neural induction with a dopaminergic phenotype from human pluripotent stem cells through a feeder-free fl oating aggregation culture. Methods Mol Biol, 1018, 11-19. doi:10. 1007/978-1-62703-444-9-2
165. Myers, R. H. (2004). Huntington's disease genetics. NeuroRx, 1, 255-262. doi:10. 1602/neurorx. 1. 2. 255 (Pubitemid 46589355)
166. Nakano, T., Ando, S., Takata, N., Kawada, M., Muguruma, K., Sekiguchi, K., et al. (2012). Self-formation of optic cupsand storable stratifi ed neural retina from human ESCs. Stem Cell, 10, 771-785. doi:10. 1016/j. stem. 2012. 05. 009
167. Nayler, S., Gatei, M., Kozlov, S., Gatti, R., Mar, J. C., Wells, C. A., et al. (2012). Induced pluripotent stem cells from ataxiatelangiectasia recapitulate the cellular phenotype. Stem Cells Transl Med, 1, 523-535. doi:10. 5966/sctm. 2012-0024
168. Nguyen, H. N., Byers, B., Cord, B., Shcheglovitov, A., Byrne, J., Gujar, P., et al. (2011). LRRK2 mutant iPSCderived DA neurons demonstrate increased susceptibilityto oxidative stress. Stem Cell, 8, 267-280. doi:10. 1016/j. stem. 2011. 01. 013
169. Nicholas, C. R., Chen, J., Tang, Y., Southwell, D. G., Chalmers, N., Vogt, D., et al. (2013). Functional maturation of hPSC-derived forebrain interneurons requires an extended timelineand mimics human neural development. Stem Cell, 12, 573-586. doi:10. 1016/j. stem. 2013. 04. 005
170. Nilbratt, M., Porras, O., Marutle, A., Hovatta, O., & Nordberg, A. (2009). Neurotrophic factors promote cholinergic differentiation in human embryonic stem cell-derived neurons. J Cell Mol Med, 14 (6b), 1476-1484. doi:10. 1111/j. 1582-4934. 2009. 00916. x
171. Nistor, G. I., Totoiu, M. O., Haque, N., Carpenter, M. K., & Keirstead, H. S. (2004). Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia, 49, 385-396. doi:10. 1002/glia. 20127
172. Nizzardo, M., Simone, C., Falcone, M., Locatelli, F., Riboldi, G., Comi, G. P., & Corti, S. (2010). Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells. Cell Mol Life Sci, 67, 3837-3847, doi:10. 1007/s00018-010-0463-y.
173. Oblak, A. L., Rosene, D. L., Kemper, T. L., Bauman, M. L., & Blatt, G. J. (2011). Altered posterior cingulate cortical cyctoarchitecture, but normal density of neurons and interneurons in the posterior cingulate cortex and fusiform gyrus in autism. Autism Res, 4, 200-211. doi:10. 1002/aur. 188
174. Ogawa, S.-I., Tokumoto, Y., Miyake, J., & Nagamune, T. (2011). Induction of oligodendrocyte differentiation from adult human fi broblast-derived induced pluripotent stem cells. In Vitro Cell Dev Biol Anim, 47, 464-469. doi:10. 1007/s11626-011-9435-2
175. Osafune, K., Caron, L., Borowiak, M., Martinez, R. J., Fitz-Gerald, C. S., Sato, Y., et al. (2008). Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol, 26, 313-315. doi:10. 1038/nbt1383 (Pubitemid 351355125)
176. Osakada, F., Ikeda, H., Mandai, M., Wataya, T., Watanabe, K., Yoshimura, N., et al. (2008). Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol, 26, 215-224. doi:10. 1038/nbt1384 (Pubitemid 351225958)
177. Osakada, F., Ikeda, H., Sasai, Y., & Takahashi, M. (2009a). Stepwise differentiation of pluripotent stem cells into retinal cells. Nat Protocols, 4, 811-824. doi:10. 1038/nprot. 2009. 51
178. Osakada, F., Jin, Z. B., Hirami, Y., Ikeda, H., Danjyo, T., Watanabe, K., et al. (2009b). In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci, 122, 3169-3179. doi:10. 1242/jcs. 050393
179. Pankratz, M. T., Li, X.-J., LaVaute, T. M., Lyons, E. A., Chen, X., & Zhang, S.-C. (2007). Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells, 25, 1511-1520. doi:10. 1634/stemcells. 2006-0707 (Pubitemid 47106020)
180. Park, C.-H., Minn, Y.-K., Lee, J.-Y., Choi, D. H., Chang, M.-Y., Shim, J.-W., et al. (2005). In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J Neurochem, 92, 1265-1276. doi:10. 1111/j. 1471-4159. 2004. 03006. x (Pubitemid 40344315)
181. Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., et al. (2007). Reprogramming of human somatic cells to pluripotency with defi ned factors. Nature, 451, 141-146. doi:10. 1038/nature06534
182. Paşca, S. P., Portmann, T., Voineagu, I., Yazawa, M., Shcheglovitov, A., Pasca, A. M., et al. (2011). Using iPSCderived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Med, 17, 1657-1662. doi:10. 1038/nm. 2576
183. Pattanayak, V., Lin, S., Guilinger, J. P., Ma, E., Doudna, J. A., & Liu, D. R. (2013). High-throughput profi ling of off-target DNA cleavage reveals rNA-programmed Cas9 nuclease specifi city. Nat Biotechnol, 31, 839-837. doi:10. 1038/nbt. 2673
184. Paulsen, B. D. S., de Moraes Maciel, R., Galina, A., Souza da Silveira, M., Santos Souza, dos, C., Drummond, H., et al. (2012). Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient. Cell Transplant, 21, 1547-1559. doi:10. 3727/096368911X600957
185. Pedrosa, E., Sandler, V., Shah, A., Carroll, R., Chang, C., Rockowitz, S., et al. (2011). Development of patientspecifi c neurons in schizophrenia using induced pluripotent stem cells. J Neurogenet, 25, 88-103. doi:10. 3109/01677063. 2011. 597908
186. Perrier, A. L., Tabar, V., Barberi, T., Rubio, M. E., Bruses, J., Topf, N., et al. (2004). Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A, 101, 12543-12548. doi:10. 1073/pnas. 0404700101 (Pubitemid 39122060)
187. Pescosolido, M. F., Yang, U., Sabbagh, M., & Morrow, E. M. (2012). Lighting a path: Genetic studies pinpoint neurodevelopmental mechanisms in autism and related disorders. Dialogues Clin Neurosci, 14, 239-252.
188. Phillips, M. J., Wallace, K. A., Dickerson, S. J., Miller, M. J., Verhoeven, A. D., Martin, J. M., et al. (2012). Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses. Invest Ophthalmol Vis Sci, 53, 2007-2019. doi:10. 1167/iovs. 11-9313
189. Pomp, O., Brokhman, I., Ben-Dor, I., Reubinoff, B., & Goldstein, R. S. (2005). Generation of peripheral sensory and sympathetic neurons and neural crest cells from human embryonic stem cells. Stem Cells, 23, 923-930. doi:10. 1634/stemcells. 2005-0038 (Pubitemid 41170948)
190. Ramirez, C. L., Certo, M. T., Mussolino, C., Goodwin, M. J., Cradick, T. J., McCaffrey, A. P., et al. (2012). Engineered zinc fi nger nickases induce homology-directed repair with reduced mutagenic effects. Nucleic Acids Res, 40, 5560-5568. doi:10. 1093/nar/gks179
191. Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., et al. (2013). Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specifi city. Cell, 154, 1380-1389. doi:10. 1016/j. cell. 2013. 08. 021
192. Reinhardt, P., Schmid, B., Burbulla, L. F., Sch ö ndorf, D. C., Wagner, L., Glatza, M., et al. (2013). Genetic correction of a LRRK2 mutationin human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Stem Cell, 12, 354-367. doi:10. 1016/j. stem. 2013. 01. 008
193. Robicsek, O., Karry, R., Petit, I., Salman-Kesner, N., ller, F.-J. M. U., Klein, E., et al. (2013). Abnormal neuronal differentiation and mitochondrial dysfunctionin hair folliclederived induced pluripotent stem cells ofschizophrenia patients. Mol Psychiatry, 18, 1067-1076. doi:10. 1038/mp. 2013. 67
194. Roy, N. S., Cleren, C., Singh, S. K., Yang, L., Beal, M. F., & Goldman, S. A. (2006). Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med, 12, 1259-1268. doi:10. 1038/nm1495 (Pubitemid 44706928)
195. Roy, N. S., Nakano, T., Xuing, L., Kang, J., Nedergaard, M., & Goldman, S. A. (2005). Enhancer-specifi ed GFPbased FACS purifi cation of human spinal motor neurons from embryonic stem cells. Exp Neurol, 196, 224-234. doi:10. 1016/j. expneurol. 2005. 06. 021 (Pubitemid 41607810)
196. Sanders, L. H., Laganière, J., Cooper, O., Mak, S. K., Vu, B. J., Huang, Y. A., et al. (2013). LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: Reversal by gene correction. Neurobiol Dis, 62C, 381-386. doi:10. 1016/j. nbd. 2013. 10. 013
197. Sandoe, J., & Eggan, K. (2013). Opportunities and challenges of pluripotent stem cell neurodegenerative disease models. Nat Neurosci, 16, 780-789. doi:10. 1038/nn. 3425
198. Sareen, D., O'Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., et al. (2013). Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med, 5, 208ra149. doi:10. 1126/scitranslmed. 3007529
199. S á nchez-Dan é s, A., Richaud-Patin, Y., Carballo-Carbajal, I., Jiménez-Delgado, S., Caig, C., Mora, S., et al. (2012). Disease-specifi c phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. EMBO Mol Med, 4, 380-395. doi:10. 1002/emmm. 201200215
200. Seibler, P., Graziotto, J., Jeong, H., Simunovic, F., Klein, C., & Krainc, D. (2011). Mitochondrial parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J Neurosci, 31, 5970-5976. doi:10. 1523/JNEUROSCI. 4441-10. 2011
201. Shcheglovitov, A., Shcheglovitova, O., Yazawa, M., Portmann, T., Shu, R., Sebastiano, V., et al. (2013). SHANK3 and IGF1 restore synaptic defi cits in neurons from 22q13 deletion syndrome patients. Nature, 503, 267-271. doi:10. 1038/nature12618
202. Sheridan, S. D., Theriault, K. M., Reis, S. A., Zhou, F., Madison, J. M., Daheron, L., et al. (2011). Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS ONE, 6, e26203. doi:10. 1371/journal. pone. 0026203. s002
203. Shi, Y., Kirwan, P., Smith, J., Robinson, H. P. C., & Livesey, F. J. (2012). Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat Neurosci, 15, 477-486. doi:10. 1038/nn. 3041
204. Singh, R., Shen, W., Kuai, D., Martin, J. M., Guo, X., Smith, M. A., et al. (2013). iPS cell modeling of Best disease: Insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet, 22, 593-607. doi:10. 1093/hmg/dds469
205. Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., et al. (2009). Parkinson' s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 136, 964-977. doi:10. 1016/j. cell. 2009. 02. 013
206. Soldner, F., Laganière, J., Cheng, A. W., Hockemeyer, D., Gao, Q., Alagappan, R., et al. (2011). Generation of isogenic pluripotent stem cells differing exclusively at two early onset parkinson point mutations. Cell, 146, 318-331. doi:10. 1016/j. cell. 2011. 06. 019
207. Sonntag, K.-C., Pruszak, J., Yoshizaki, T., van Arensbergen, J., S á nchez-Pernaute, R., & Isacson, O. (2007). Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells, 25, 411-418. doi:10. 1634/stemcells. 2006-0380 (Pubitemid 46232796)
208. Stilo, S. A., & Murray, R. M. (2010). The epidemiology of schizophrenia: Replacing dogma with knowledge. Dialogues Clin Neurosci, 12, 305-315.
209. Su, Y. C., & Qi, X. (2013). Inhibition of excessive mitochondrial fi ssion reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation. Hum Mol Genet. 22, 4545-4561. doi:10. 1093/hmg/ddt301
210. Swistowski, A., Peng, J., Liu, Q., Mali, P., Rao, M. S., Cheng, L., & Zeng, X. (2010). Effi cient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defi ned conditions. Stem Cells, 28, 1893-1904. doi:10. 1002/stem. 499
211. Szczepek, M., Brondani, V., Büchel, J., Serrano, L., Segal, D. J., & Cathomen, T. (2007). Structure-based redesign of the dimerization interface reduces the toxicity of zinc-fi nger nucleases. Nat Biotechnol, 25, 786-793. doi:10. 1038/nbt1317 (Pubitemid 47052189)
212. Tabar, V., Panagiotakos, G., Greenberg, E. D., Chan, B. K., Sadelain, M., Gutin, P. H., & Studer, L. (2005). Migration and differentiation of neural precursors derived from human embryonic stem cells in the rat brain. Nat Biotechnol, 23, 601-606. doi:10. 1038/nbt1088 (Pubitemid 41724899)
213. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fi broblasts by defi ned factors. Cell, 131, 861-872. doi:10. 1016/j. cell. 2007. 11. 019 (Pubitemid 350138099)
214. Takazawa, T., Croft, G. F., Amoroso, M. W., Studer, L., Wichterle, H., & MacDermott, A. B. (2012). Maturation of spinal motor neurons derived from human embryonic stem cells. PLoS ONE, 7, e40154. doi:10. 1371/journal. pone. 0040154. g004
215. Tau, G. Z., & Peterson, B. S. (2009). Normal development of brain circuits. Neuropsychopharmacology, 35, 147-168. doi:10. 1038/npp. 2009. 115
216. Tesson, L., Usal, C., M é noret1, S., Leung, E., Niles, B. J., Remy, S., et al. (2011). Knockout rats generated by embryo microinjection of TALENs. Nature Biotechnology, 29, 695-696. doi:10. 1038/nbt. 1940
217. Thies, W., & Bleiler, L. (2013). 2013 Alzheimer's disease facts and fi gures. Alzheimer's & Dementia: the Journal of the Alzheimer's Association. 9, 208-245. doi:10. 1016/j. jalz. 2013. 02. 003
218. Tiscornia, G., Lorenzo Vivas, E., Matalonga, L., Berniakovich, I., Barragan Monasterio, M., Eguizabal, C., et al. (2013). Neuronopathic Gaucher's disease: Induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds. Hum Mol Genet, 22, 633-645. doi:10. 1093/hmg/dds471
219. Tran, N. N., Ladran, I. G., & Brennand, K. J. (2012). Modeling schizophrenia using induced pluripotent stem cell-derived and fi broblast-induced neurons. Schizophr Bull, 39, 4-10. doi:10. 1093/schbul/sbs127
220. Trilck, M., bner, R. H., Seibler, P., Klein, C., Rolfs, A., & Frech, M. J. (2013). Niemann-Pick type C1 patient-specifi c induced pluripotent stem cells display disease specifi c hallmarks. Orphanet J Rare Dis, 8, 144. doi:10. 1186/1750-1172-8-144
221. Tucker, B. A., Scheetz, T. E., Mullins, R. F., DeLuca, A. P., Hoffmann, J. M., Johnston, R. M., et al. (2011). Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa. Proc Natl Acad Sci U S A, 108, E569-E576. doi:10. 1073/pnas. 1108918108
222. T ø nnesen, J., Parish, C. L., S ø rensen, A. T., Andersson, A., Lundberg, C., Deisseroth, K., et al. (2011). Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model. PLoS ONE, 6, e17560. doi:10. 1371/journal. pone. 0017560
223. Urbach, A., Bar-Nur, O., Daley, G. Q., & Benvenisty, N. (2010). Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Stem Cell, 6, 407-411. doi:10. 1016/j. stem. 2010. 04. 005
224. Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010). Genome editing with engineered zinc fi nger nucleases. Nat Rev Genet, 11, 636-646. doi:10. 1038/nrg2842
225. Vaccarino, F. M., Stevens, H. E., Kocabas, A., Palejev, D., Szekely, A., Grigorenko, E. L., & Weissman, S. (2011). Induced pluripotent stem cells: A new tool to confront the challenge of neuropsychiatric disorders. Neuropharmacology, 60, 1355-1363. doi:10. 1016/j. neuropharm. 2011. 02. 021
226. Valensi-Kurtz, M., Lefl er, S., Cohen, M. A., Aharonowiz, M., Cohen-Kupiec, R., Sheinin, A., et al. (2010). Enriched population of PNS neurons derived from human embryonic stem cells as a platform for studying peripheral neuropathies. PLoS ONE, 5, e9290. doi:10. 1371/journal. pone. 0009290. s004
227. Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011). Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol, 10, 241-252. doi:10. 1016/S1474-4422(10)70325-2
228. Vitale, A. M., Matigian, N. A., Ravishankar, S., Bellette, B., Wood, S. A., Wolvetang, E. J., & Mackay-Sim, A. (2012). Variability in the generation of induced pluripotent stem cells: Importance for disease modeling. Stem Cells Transl Med, 1, 641-650. doi:10. 5966/sctm. 2012-0043
229. Wada, T., Honda, M., Minami, I., Tooi, N., Amagai, Y., Nakatsuji, N., & Aiba, K. (2009). Highly effi cient differentiation and enrichment of spinal motor neurons derived from human and monkey embryonic stem cells. PLoS ONE, 4, e6722. doi:10. 1371/journal. pone. 0006722. s009
230. Walker, F. O. (2007). Huntington's disease. Lancet, 369, 218-228. doi:10. 1016/S0140-6736(07)60111-1 (Pubitemid 46107685)
231. Wang, J., Friedman, G., Doyon, Y., Wang, N. S., Li, C. J., Miller, J. C., et al. (2012). Targeted gene addition to a predetermined site in the human genome using a ZFN-based nicking enzyme. Genome Res, 22, 1316-1326. doi:10. 1101/gr. 122879. 111
232. Wang, S., Bates, J., Li, X., Schanz, S., Chandler-Militello, D., Levine, C., et al. (2013). Clinical progress. Stem Cell, 12, 252-264. doi:10. 1016/j. stem. 2012. 12. 002
233. Watanabe, K., Kamiya, D., Nishiyama, A., Katayama, T., Nozaki, S., Kawasaki, H., et al. (2005). Directed differentiation of telencephalic precursors from embryonic stem cells. Nat Neurosci, 8, 288-296. doi:10. 1038/nn1402 (Pubitemid 40300185)
234. Wernig, M., Zhao, J.-P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., et al. (2008). Neurons derived from reprogrammed fi broblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A, 105, 5856-5861. doi:10. 1073/pnas. 0801677105 (Pubitemid 351758462)
235. Wicklund, L., Le ã o, R. N., Str ö mberg, A.-M., Mousavi, M., Hovatta, O., Nordberg, A., & Marutle, A. (2010). Amyloid 1-42 oligomers impair function of human embryonic stem cell-derived forebrain cholinergic neurons. PLoS ONE, 5, e15600. doi:10. 1371/journal. pone. 0015600. s007
236. Wood, A. J., Lo, T.-W., Zeitler, B., Pickle, C. S., Ralston, E. J., Lee, A. H., et al. (2011). Targeted genome editing across species using ZFNs and TALENs. Science, 333, 307. doi:10. 1126/science. 1207773
237. Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Yoshizaki, T., et al. (2011). Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet, 20, 4530-4539. doi:10. 1093/hmg/ddr394
238. Yan, Y., Yang, D., Zarnowska, E. D., Du, Z., Werbel, B., Valliere, C., et al. (2005). Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells, 23, 781-790. doi:10. 1634/stemcells. 2004-0365 (Pubitemid 40791793)
239. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917-1920. doi:10. 1126/science. 1151526
240. Yuan, S. H., Martin, J., Elia, J., Flippin, J., Paramban, R. I., Hefferan, M. P., et al. (2011). Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS ONE, 6, e17540. doi:10. 1371/journal. pone. 0017540. s006
241. Zeng, H., Guo, M., Martins-Taylor, K., Wang, X., Zhang, Z., Park, J. W., et al. (2010). Specifi cation of region-specifi c neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells. PLoS ONE, 5, e11853. doi:10. 1371/journal. pone. 0011853
242. Zhang, J., Lian, Q., Zhu, G., Zhou, F., Sui, L., Tan, C., et al. (2011). A human iPSC model of Hutchinson Gilford progeria reveals vascular smooth muscleand mesenchymal stem cell defects. Stem Cell, 8, 31-45. doi:10. 1016/j. stem. 2010. 12. 002
243. Zhang, S. C., Wernig, M., Duncan, I. D., Brüstle, O., & Thomson, J. A. (2001). In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol, 19, 1129-1133. doi:10. 1038/nbt1201-1129 (Pubitemid 33115698)
244. Zhang, X.-Q., & Zhang, S.-C. (2009). Differentiation of neural precursors and dopaminergic neurons from human embryonic stem cells. Methods Mol Biol, 584, 355-366. doi:10. 1007/978-1-60761-369-5-19
245. Ziegler, L., Grigoryan, S., Yang, I. H., Thakor, N. V., & Goldstein, R. S. (2010). Effi cient generation of schwann cells from human embryonic stem cellderived neurospheres. Stem Cell Rev Rep, 7, 394-403. doi:10. 1007/s12015-010-9198-2